title: The essentiality of alpha-2-macroglobulin in human salivary innate immunity against new H1N1 swine origin influenza A virus.
abstract: A novel strain of influenza A H1N1 emerged in the spring of 2009 and has spread rapidly throughout the world. Although vaccines have recently been developed that are expected to be protective, their availability was delayed until well into the influenza season. Although anti-influenza drugs such as neuraminidase inhibitors can be effective, resistance to these drugs has already been reported. Although human saliva was known to inhibit viral infection and may thus prevent viral transmission, the components responsible for this activity on influenza virus, in particular, influenza A swine origin influenza A virus (S-OIV), have not yet been defined. By using a proteomic approach in conjunction with beads that bind alpha-2,6-sialylated glycoprotein, we determined that an alpha-2-macroglobulin (A2M) and an A2M-like protein are essential components in salivary innate immunity against hemagglutination mediated by a clinical isolate of S-OIV (San Diego/01/09 S-OIV). A model of an A2M-based "double-edged sword" on competition of alpha-2,6-sialylated glycoprotein receptors and inactivation of host proteases is proposed. We emphasize that endogenous A2M in human innate immunity functions as a natural inhibitor against S-OIV.
authors.affiliation: Division of Dermatology, Department of Medicine, University of California, San Diego, CA 92121, USA.
authors.forename: Chao-Hsuan
authors.initials: CH
authors.lastname: Chen
authors.forename: Xing-Quan
authors.initials: XQ
authors.lastname: Zhang
authors.forename: Chih-Wei
authors.initials: CW
authors.lastname: Lo
authors.forename: Pei-Feng
authors.initials: PF
authors.lastname: Liu
authors.forename: Yu-Tsueng
authors.initials: YT
authors.lastname: Liu
authors.forename: Richard L
authors.initials: RL
authors.lastname: Gallo
authors.forename: Ming-Fa
authors.initials: MF
authors.lastname: Hsieh
authors.forename: Robert T
authors.initials: RT
authors.lastname: Schooley
authors.forename: Chun-Ming
authors.initials: CM
authors.lastname: Huang
mesh_terms: D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007251:Influenza, Human / Q000276:immunology*; D008962:Models, Theoretical; D012463:Saliva / Q000276:immunology*; D000511:alpha-Macroglobulins / Q000276:immunology*
chemical_list: D006023:Glycoproteins; D000511:alpha-Macroglobulins
references.citation: J Biol Chem. 1989 Jun 15;264(17):9850-8
references.pmid: 2470765
references.citation: Virology. 1983 Jun;127(2):361-73
references.pmid: 6868370
references.citation: Acta Pathol Microbiol Scand. 1965;64:224-8
references.pmid: 14329861
references.citation: J Virol. 2009 Apr;83(8):3754-61
references.pmid: 19211766
references.citation: Virology. 1983 Dec;131(2):394-408
references.pmid: 6197808
references.citation: Proteomics Clin Appl. 2008 Sep;2(9):1234-45
references.pmid: 21136919
references.citation: Nat Rev Microbiol. 2006 Jul;4(7):529-36
references.pmid: 16778838
references.citation: Am J Respir Crit Care Med. 2003 Jul 15;168(2):199-207
references.pmid: 12689849
references.citation: Clin Chim Acta. 1987 Jun 15;165(2-3):277-88
references.pmid: 2443279
references.citation: Virology. 1997 Jan 20;227(2):493-9
references.pmid: 9018149
references.citation: Proteomics. 2003 Oct;3(10):1980-7
references.pmid: 14625860
references.citation: Protein Expr Purif. 2008 Jan;57(1):72-80
references.pmid: 18029197
references.citation: Proteomics. 2008 Aug;8(16):3406-15
references.pmid: 18651708
references.citation: J Immunol. 1949 Nov;63(3):261-71
references.pmid: 15393958
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L1066-76
references.pmid: 12871854
references.citation: Nat Biotechnol. 2009 Sep;27(9):797-9
references.pmid: 19741625
references.citation: J Clin Microbiol. 2009 Sep;47(9):3060-1
references.pmid: 19605579
references.citation: Virology. 1975 Dec;68(2):440-54
references.pmid: 128196
references.citation: Virology. 1974 Oct;61(2):397-410
references.pmid: 4472498
references.citation: Arch Oral Biol. 1995 Dec;40(12):1151-5
references.pmid: 8850655
references.citation: Oral Microbiol Immunol. 2009 Feb;24(1):18-24
references.pmid: 19121065
references.citation: J Gen Virol. 1969 Jul;5(1):141-3
references.pmid: 5823666
references.citation: Virology. 1975 Dec;68(2):426-39
references.pmid: 173078
references.citation: Trends Microbiol. 1994 Feb;2(2):39-43
references.pmid: 8162439
references.citation: Virology. 1999 May 25;258(1):1-20
references.pmid: 10329563
references.citation: In Vitro Cell Dev Biol. 1991 Mar;27A(3 Pt 1):183-4
references.pmid: 2033016
references.citation: Acta Pathol Microbiol Scand. 1965;63:291-8
references.pmid: 14301676
references.citation: Proc Soc Exp Biol Med. 1948 Nov;69(2):291-4
references.pmid: 18102207
references.citation: Ann Acad Med Stetin. 2006;52(2):33-7; discussion 37
references.pmid: 17633124
references.citation: Cell. 2009 Dec 24;139(7):1243-54
references.pmid: 20064371
references.citation: J Biol Chem. 2006 Mar 3;281(9):5780-9
references.pmid: 16298998
references.citation: FASEB J. 1992 Dec;6(15):3345-53
references.pmid: 1281457
references.citation: J Biol Chem. 1989 Jun 15;264(17):9842-9
references.pmid: 2470764
references.citation: Swiss Med Wkly. 2008 Apr 5;138(13-14):191-6
references.pmid: 18389391
references.citation: Proteomics Clin Appl. 2009 Jul 1;3(7):810-820
references.pmid: 20011683
references.citation: Pneumonol Alergol Pol. 2005;73(1):12-7
references.pmid: 16539178